Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Clinical trial NCT02701400 · COMPLETED
Trial details
- NCT number
- NCT02701400
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2020-08-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.